Home Cart Sign in  
Chemical Structure| 96990-18-0 Chemical Structure| 96990-18-0

Structure of Momordin Ic
CAS No.: 96990-18-0

Chemical Structure| 96990-18-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Momordin Ic is a SUMO-specific protease 1 (SENP1) inhibitor and a SENP1/c-MYC signaling pathway inhibitor. Momordin Ic induces apoptosis by modulating mitochondrial dysfunction through oxidative stress of iNOS and HO-1 pathways mediated by MAPK and PI3K.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Momordin Ic

CAS No. :96990-18-0
Formula : C41H64O13
M.W : 764.94
SMILES Code : O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O[C@H]2[C@@H]([C@H]([C@@H](CO2)O)O)O)[C@@H]1O[C@H]3CC[C@]4(C)[C@@]5([H])CC=C6[C@]7([H])CC(C)(C)CC[C@]7(C(O)=O)CC[C@](C)6[C@@](C)5CC[C@@]4([H])C3(C)C
MDL No. :MFCD11042256
InChI Key :HWYBGIDROCYPOE-WEAQAMGWSA-N
Pubchem ID :176596

Safety of Momordin Ic

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 breast cancer cells 25 µM 9 days Combined treatment with Momordin Ic and Gallic Acid significantly inhibits tumor spheroid growth Cells. 2023 Mar 7;12(6):825
MIAPaCa-2 pancreatic cancer cells 25 µM 9 days Combined treatment with Momordin Ic and Gallic Acid significantly inhibits tumor spheroid growth Cells. 2023 Mar 7;12(6):825
HCT116 colon cancer cells 25 µM 9 days Combined treatment with Momordin Ic and Gallic Acid significantly inhibits tumor spheroid growth Cells. 2023 Mar 7;12(6):825
C-33A cervical cancer cells 25 µM 6, 12, 24, 48 hours Momordin Ic inhibits tumor cell proliferation by promoting abnormal SUMOylation of pH3(Ser10) Cells. 2023 Mar 7;12(6):825
CaSki cervical cancer cells 25 µM 6, 12, 24, 48 hours Momordin Ic inhibits tumor cell proliferation by promoting abnormal SUMOylation of pH3(Ser10) Cells. 2023 Mar 7;12(6):825
WM793 2.0 µg/mL (24 h), 1.0 µg/mL (48 h) 24 h and 48 h Exhibits potent cytotoxicity against WM793 cells Molecules. 2024 Aug 10;29(16):3794
A375 1.9 µg/mL (24 h), 0.9 µg/mL (48 h) 24 h and 48 h Exhibits potent cytotoxicity against A375 cells Molecules. 2024 Aug 10;29(16):3794
HCT-116 9.4 µg/mL (24 h), 8.3 µg/mL (48 h) 24 h and 48 h Inhibits HCT-116 cell proliferation via suppression of SENP1/c-Myc signaling pathway Molecules. 2024 Aug 10;29(16):3794
HT-29 4.2 µg/mL (24 h), 2.9 µg/mL (48 h) 24 h and 48 h Inhibits HT-29 cell proliferation via suppression of SENP1/c-Myc signaling pathway Molecules. 2024 Aug 10;29(16):3794
HepG2 12.5 µg/mL (24 h), 9.5 µg/mL (48 h) 24 h and 48 h Induces apoptosis in HepG2 cells via MAPK- and PI3K/Akt-mediated pathways Molecules. 2024 Aug 10;29(16):3794
Du-145 5.4 µg/mL (24 h), 2.8 µg/mL (48 h) 24 h and 48 h Inhibits Du-145 cell proliferation via suppression of SENP1/c-Myc signaling pathway Molecules. 2024 Aug 10;29(16):3794
PC3 5.5 µg/mL (24 h), 3.4 µg/mL (48 h) 24 h and 48 h Inhibits PC3 cell proliferation via suppression of SENP1/c-Myc signaling pathway Molecules. 2024 Aug 10;29(16):3794
TOV2414 24.3 µM ±13.09 5 days Evaluate the cytotoxic effect of Momordin Ic on TOV2414 cells, IC50 was 24.3 µM ±13.09 Int J Mol Sci. 2025 Jan 8;26(2):472
MCAS 33.01 µM ±10.53 5 days Evaluate the cytotoxic effect of Momordin Ic on MCAS cells, IC50 was 33.01 µM ±10.53 Int J Mol Sci. 2025 Jan 8;26(2):472
OCM.72 10.68 µM ±1.08 5 days Evaluate the cytotoxic effect of Momordin Ic on OCM.72 cells, IC50 was 10.68 µM ±1.08 Int J Mol Sci. 2025 Jan 8;26(2):472
EFO27 13.19 ±1.43 µM 5 days Evaluate the cytotoxic effect of Momordin Ic on EFO27 cells, IC50 was 13.19 ±1.43 µM Int J Mol Sci. 2025 Jan 8;26(2):472
THP1 macrophages 2 µM 24 hours Evaluate the inhibitory effect of Momordin Ic on THP1 macrophage infection, results showed Momordin Ic significantly inhibited HCMV infection Pathogens. 2024 Jun 28;13(7):546
Adult retinal pigment epithelial cells (ARPE-19) 2 µM 24 hours Evaluate the inhibitory effect of Momordin Ic on ARPE-19 cell infection, results showed Momordin Ic significantly inhibited HCMV infection Pathogens. 2024 Jun 28;13(7):546
Human foetal foreskin fibroblasts (HFFs) 1.25 µM 24 hours Evaluate the inhibitory effect of Momordin Ic on HCMV infection, results showed Momordin Ic significantly inhibited HCMV infection Pathogens. 2024 Jun 28;13(7):546

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Pressure overload-induced cardiac hypertrophy model Intraperitoneal injection 10 mg/kg Once daily for 20 consecutive days Momordin Ic accelerated pressure overload-induced cardiac remodeling J Am Heart Assoc. 2022 Nov 15;11(22):e027004
NOD/SCID mice AML xenograft model Intraperitoneal injection 10 mg/kg Ara-C for 5 consecutive days, Momordin Ic every two days for a week To evaluate the effect of Momordin Ic combined with Ara-C on AML xenograft model, results showed that combination therapy significantly reduced AML cell survival and improved mouse survival. Int J Mol Sci. 2022 Jul 27;23(15):8282

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.31mL

0.26mL

0.13mL

6.54mL

1.31mL

0.65mL

13.07mL

2.61mL

1.31mL

References

[1]Wang J, Yuan L, et al. Momordin Ic induces HepG2 cell apoptosis through MAPK and PI3K/Akt-mediated mitochondrial pathways. Apoptosis. 2013 Jun;18(6):751-65.

[2]Kim NY, Lee MK, et al. Momordin Ic and oleanolic acid from Kochiae Fructus reduce carbon tetrachloride-induced hepatotoxicity in rats. J Med Food. 2005 Summer;8(2):177-83.

[3]Mi Y, Xiao C, Du Q, Wu W, Qi G, Liu X. Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways. Free Radic Biol Med. 2016 Jan;90:230-42

[4]Wang J, Liu Q, Xiao H, Luo X, Liu X. Suppressive effects of Momordin Ic on HepG2 cell migration and invasion by regulating MMP-9 and adhesion molecules: Involvement of p38 and JNK pathways. Toxicol In Vitro. 2019 Apr;56:75-83

[5]Xianjun F, Xirui X, Jie T, Huiwen M, Shaojun Z, Qiaoyun L, Yunxin L, Xuqun S. Momordin Ic induces G0/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1/c-MYC signaling pathway. J Pharmacol Sci. 2021 Aug;146(4):249-258

[6]Zheng C, Li D, Zhan W, He K, Yang H. Downregulation of SENP1 suppresses LPS-induced macrophage inflammation by elevating Sp3 SUMOylation and disturbing Sp3-NF-κB interaction. Am J Transl Res. 2020 Nov 15;12(11):7439-7448

[7]Yoo SR, Jeong SJ, Lee NR, Shin HK, Seo CS. Quantification Analysis and In Vitro Anti-Inflammatory Effects of 20-Hydroxyecdysone, Momordin Ic, and Oleanolic Acid from the Fructus of Kochia scoparia. Pharmacogn Mag. 2017 Jul-Sep;13(51):339-344

 

Historical Records

Categories